These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 10433957

  • 1. Estrogen receptor expression in prostate cancer and premalignant prostatic lesions.
    Bonkhoff H, Fixemer T, Hunsicker I, Remberger K.
    Am J Pathol; 1999 Aug; 155(2):641-7. PubMed ID: 10433957
    [Abstract] [Full Text] [Related]

  • 2. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
    Fixemer T, Remberger K, Bonkhoff H.
    Prostate; 2003 Feb 01; 54(2):79-87. PubMed ID: 12497580
    [Abstract] [Full Text] [Related]

  • 3. Progesterone receptor expression in human prostate cancer: correlation with tumor progression.
    Bonkhoff H, Fixemer T, Hunsicker I, Remberger K.
    Prostate; 2001 Sep 15; 48(4):285-91. PubMed ID: 11536308
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer.
    Fujimura T, Takahashi S, Urano T, Ogawa S, Ouchi Y, Kitamura T, Muramatsu M, Inoue S.
    Biochem Biophys Res Commun; 2001 Dec 07; 289(3):692-9. PubMed ID: 11726203
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue.
    Hobisch A, Rogatsch H, Hittmair A, Fuchs D, Bartsch G, Klocker H, Bartsch G, Culig Z.
    J Pathol; 2000 Jul 07; 191(3):239-44. PubMed ID: 10878544
    [Abstract] [Full Text] [Related]

  • 6. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.
    Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H, Ho SM.
    Am J Pathol; 2001 Jul 07; 159(1):79-92. PubMed ID: 11438457
    [Abstract] [Full Text] [Related]

  • 7. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Bostwick DG.
    J Urol; 1999 Apr 07; 161(4):1229-32. PubMed ID: 10081875
    [Abstract] [Full Text] [Related]

  • 8. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D, Simak R, Steiner GE, Handisurya A, Susani M, Marberger M.
    J Urol; 2000 Aug 07; 164(2):506-10. PubMed ID: 10893635
    [Abstract] [Full Text] [Related]

  • 9. Estrogen receptor gene expression and its relation to the estrogen-inducible HSP27 heat shock protein in hormone refractory prostate cancer.
    Bonkhoff H, Fixemer T, Hunsicker I, Remberger K.
    Prostate; 2000 Sep 15; 45(1):36-41. PubMed ID: 10960840
    [Abstract] [Full Text] [Related]

  • 10. Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression.
    Bonkhoff H.
    Prostate; 2018 Jan 15; 78(1):2-10. PubMed ID: 29094395
    [Abstract] [Full Text] [Related]

  • 11. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T, Herawi M, Epstein JI, Illei PB.
    Am J Surg Pathol; 2007 Sep 15; 31(9):1351-5. PubMed ID: 17721190
    [Abstract] [Full Text] [Related]

  • 12. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR, Faith D, Li X, Guan B, Hicks JL, Lan F, Jenkins RB, Bieberich CJ, De Marzo AM.
    Cancer Res; 2006 Nov 15; 66(22):10683-90. PubMed ID: 17108105
    [Abstract] [Full Text] [Related]

  • 13. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
    Väisänen MR, Väisänen T, Jukkola-Vuorinen A, Vuopala KS, Desmond R, Selander KS, Vaarala MH.
    Prostate; 2010 Jun 01; 70(8):817-24. PubMed ID: 20054821
    [Abstract] [Full Text] [Related]

  • 14. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
    Sasor A, Wagrowska-Danilewicz M, Danilewicz M.
    Pol J Pathol; 2000 Jun 01; 51(1):31-6. PubMed ID: 10833901
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate.
    Uetsuki H, Tsunemori H, Taoka R, Haba R, Ishikawa M, Kakehi Y.
    J Urol; 2005 Aug 01; 174(2):514-8. PubMed ID: 16006883
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.